Expectations trend
FY2028 · fiscal year ending 2028-06-30 · fmp
Selectquote, Inc. (SLQT)
NYSEFinancialsInsurance - BrokersSnapshot 2026-11-04
$0.39-20.61%
Close 2026-11-05 · 1-day change
NYSEFinancialsInsurance - BrokersSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for SLQT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain adjusted EBITDA of $90M to $100M in FY 2026 | Profit targets include $90M to $100M adjusted EBITDA and $25M to $35M operating cash flow. | Intact | adjusted EBITDA falls below $90M in FY 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-06-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk recovery story, not a steady compounder: SLQT remains loss-making on the earnings-quality measure despite improved fiscal 2026 net income and cash from operations. The thesis is in a watch state, and confidence in the evidence has fallen from medium to low.
The valuation is described as cheap versus peers, while the expectations gap is negative, suggesting expectations are already cautious. The pricing tag is justified, and no fragility gates fired, but the valuation model has low confidence.
Near term, results may remain uneven: fiscal 2026 revenue was slightly below guidance and Adjusted EBITDA declined from the prior year, even though net income and cash from operations improved. A recent earnings miss and a 47% estimated chance of missing the next print add risk; the evidence also flags a prior delisting-rule notice, without further detail.
The multi-year thesis hinges on sustained improvement in profitability and cash flow, alongside stronger revenue execution. Near term, another guidance cut would be a negative signal, while continued earnings strength from sector bellwethers could support sector momentum; a shift to rate cuts is flagged as a headwind.
Over the next 1 to 3 years, SLQT’s setup depends on whether better cash generation can persist and offset weak, inconsistent operating results. Low confidence and high risk make the evidence for the long-term thesis limited. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Selectquote, Inc.'s published investment case. The stated target is EPS >= $0.19 in FY 2027. |
| Broken |
| EPS falls below $0.19 in FY 2027 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve operating cash flow to $25M to $35M in FY 2026 | Profit targets include $90M to $100M adjusted EBITDA and $25M to $35M operating cash flow. | Intact | operating cash flow falls below $25M in FY 2026 | Cash from operations: $-3.32M FY2026-Q4; GAAP. Published target: $25M to $35M operating cash flow. Annual target cannot be compared with a quarterly or TTM observation. Aug 25, 2026-3,320,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue of $1.61B to $1.71B in FY 2026 | A primary condition in Selectquote, Inc.'s published investment case. The stated target is $1.61B to $1.71B total revenue. | Under Pressure | annual revenue falls below $1.61B in FY 2026 | Revenue: $280.007M FY2027-Q1; GAAP. Published target: $1.61B to $1.71B total revenue. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 2026280,007,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.51 → $-0.37 · observed estimates
$1.44B → $1.46B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-26 | $-0.51 | $1,442,878,000 | 1 / 1 |
| 2026-08-27 | $-0.51 | $1,442,878,000 | 1 / 1 |
| 2026-08-28 | $-0.51 | $1,442,878,000 | 1 / 1 |
| 2026-08-29 | $-0.21 | $1,443,136,000 | 1 / 2 |
| 2026-08-30 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-08-31 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-01 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-02 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-03 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-04 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-05 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-06 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-07 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-08 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-09 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-10 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-11 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-12 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-13 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-14 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-15 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-16 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-17 | $-0.28 | $1,463,902,000 | 1 / 2 |
| 2026-09-18 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-19 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-20 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-21 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-22 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-23 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-24 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-25 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-26 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-27 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-28 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-29 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-09-30 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-01 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-02 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-03 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-04 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-05 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-06 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-07 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-08 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-09 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-10 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-11 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-12 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-13 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-14 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-15 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-16 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-17 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-18 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-19 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-20 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-21 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-22 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-23 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-24 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-25 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-26 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-27 | $-0.28 | $1,463,902,000 | 1 / 3 |
| 2026-10-28 | $-0.37 | $1,463,901,900 | 1 / 3 |
| 2026-10-29 | $-0.37 | $1,463,901,900 | 1 / 3 |
| 2026-10-30 | $-0.37 | $1,463,901,900 | 1 / 3 |
| 2026-10-31 | $-0.37 | $1,463,901,900 | 1 / 3 |
| 2026-11-01 | $-0.37 | $1,463,901,900 | 1 / 3 |
| 2026-11-02 | $-0.37 | $1,463,901,900 | 1 / 3 |
| 2026-11-03 | $-0.37 | $1,463,901,900 | 1 / 3 |
| 2026-11-04 | $-0.37 | $1,463,901,900 | 1 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.